Mesalamine on Horizon Medicare Blue Rx Enhanced (S5993-003)
Covered.
Tier 4 (non-preferred drug). Quantity limit of 120 per 30 days.
$77.74
Patient pays / month, after deductible
$172.75
Patient pays / month, before the $200.00 deductible
$233.21
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap
MESALAMINE .375 g Capsule, Extended Release at a preferred retail pharmacy, from the plan's negotiated price of $172.75 for a month. Other covered strengths are listed below.
All 7 covered strengths and forms
| Form | Tier | Patient pays / month | Limits |
|---|---|---|---|
| MESALAMINE .375 g Capsule, Extended Release | 4 | $77.74 | 120 per 30 days |
| MESALAMINE 1.2 g Tablet, Delayed Release | 4 | $98.69 | 120 per 30 days |
| MESALAMINE 1000 mg Suppository | 4 | 45% | None |
| MESALAMINE 4 g/60mL Enema | 4 | 45% | None |
| MESALAMINE 400 mg Capsule, Delayed Release | 4 | $577.26 | 180 per 30 days |
| MESALAMINE 500 mg Capsule, Extended Release | 4 | $541.45 | 240 per 30 days |
| MESALAMINE 800 mg Tablet, Delayed Release | 4 | $496.10 | 180 per 30 days |
Verify with the plan before prescribing or filling. Member services: (800)391-1906. Data from the CMS 2026 Part D formulary and pricing files. Full plan details
Plan ID s5993-003